Citation: | WANG Yu, CHEN Fangfang, WANG Chao, GUO Han, WANG Suhang, LIU Mulin. Value of c-MYC expression in a lymph node metastasis risk prediction model for colon cancer[J]. Chinese Journal of General Practice, 2024, 22(3): 372-375. doi: 10.16766/j.cnki.issn.1674-4152.003405 |
[1] |
DHANASEKARAN R, DEUTZMANN A, MAHAUAD W D, et al. The MYC oncogene: the grand orchestrator of cancer growth and immune evasion[J]. Nat Rev Clin Oncol, 2022, 19(1): 23-36. doi: 10.1038/s41571-021-00549-2
|
[2] |
CHUANG J P, TSAI H L, CHEN P J, et al. Comprehensive review of biomarkers for the treatment of locally advanced colon cancer[J]. Cells, 2022, 11(23): 37-44.
|
[3] |
DUFFY M J, GRADY S, TANG M, et al. MYC as a target for cancer treatment[J]. Cancer Treat Rev, 2021, 94(2): 152-154.
|
[4] |
TANG J, YAN T, BAO Y, et al. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc[J]. Nat Commun, 2019, 10(1): 34-39. doi: 10.1038/s41467-018-08006-y
|
[5] |
GEORGE J, LI Y, KADAMBERI I P, et al. RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site[J]. Cell Rep, 2021, 37(5): 109-114.
|
[6] |
SINGH K B, HAHM E R, SINGH S V. Leelamine suppresses cMYC expression in prostate cancer cells in vitro and inhibits prostate carcinogenesis in vivo[J]. J Cancer Metastasis Treat, 2021, 7(16): 704-722.
|
[7] |
MIHASHI Y, KIMURA S, IWASAKI H, et al. Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers[J]. Diagn Pathol, 2021, 16(1): 101-105. doi: 10.1186/s13000-021-01163-7
|
[8] |
WU H, YANG T Y, LI Y, et al. Tumor necrosis factor receptor-associated factor 6 promotes hepatocarcinogenesis by interacting with histone deacetylase 3 to enhance c-Myc gene expression and protein stability[J]. Hepatology, 2020, 71(1): 148-163. doi: 10.1002/hep.30801
|
[9] |
ROBISON T H, SOLIPURAM M, HEIST K, et al. Multiparametric MRI to quantify disease and treatment response in mice with myeloproliferative neoplasms[J]. JCI Insight, 2022, 7(19): 161-167.
|
[10] |
MIN J K, KWAK M S, CHA J M. Overview of deep learning in gastrointestinal endoscopy[J]. Gut Liver, 2019, 13(4): 388-393. doi: 10.5009/gnl18384
|
[11] |
LI K, FATHAN M I, PATEL K, et al. Colonoscopy polyp detection and classification: dataset creation and comparative evaluations[J]. PLoS One, 2021, 16(8): 254-259.
|
[12] |
BLANES V, BAATRUP G, NADIMI E S. Addressing priority challenges in the detection and assessment of colorectal polyps from capsule endoscopy and colonoscopy in colorectal cancer screening using machine learning[J]. Acta Oncol, 2019, 58(sup1): S29-S36. doi: 10.1080/0284186X.2019.1584404
|
[13] |
SHINJI S, YAMADA T, MATSUDA A, et al. Recent advances in the treatment of colorectal cancer: a review[J]. Nippon Med Sch, 2022, 89(3): 246-254. doi: 10.1272/jnms.JNMS.2022_89-310
|
[14] |
YANG C Y, YEN M H, KIU K T, et al. Outcomes of right-sided and left-sided colon cancer after curative resection[J]. Sci Rep, 2022, 12(1): 118-123. doi: 10.1038/s41598-021-02808-9
|
[15] |
柳亚魁, 王栓虎. Ⅰ~Ⅲ期不同部位的左右半结肠癌临床病理特征及预后比较分析[J]. 中华全科医学, 2022, 20(4): 587-590. doi: 10.16766/j.cnki.issn.1674-4152.002406
LIU Y K, WANG S H. Comparative analysis on the clinicopathological characteristics and prognosis of left and right colon cancer at stageⅠ-Ⅲ[J]. Chinese Journal of General Practice, 2022, 20(4): 587-590. doi: 10.16766/j.cnki.issn.1674-4152.002406
|
[16] |
JIN J, ZHANG Q, DONG B, et al. Automatic detection of early gastric cancer in endoscopy based on Mask region-based convolutional neural networks (Mask R-CNN) (with video)[J]. Front Oncol, 2022, 12(9): 278-288.
|